SEC Form 4 · accession 0001127602-16-056429
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard H Anderson
Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 2:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 24, 2016 | M | 1,493 | $46.91 | A | 57,160 | D | |
| Ordinary Shares | Jun 24, 2016 | M | 1,010 | $52.84 | A | 58,170 | D | |
| Ordinary Shares | Jun 24, 2016 | M | 1,590 | $50.34 | A | 59,760 | D | |
| Ordinary Shares | Jun 24, 2016 | M | 2,671 | $29.96 | A | 62,431 | D | |
| Ordinary Shares | Jun 24, 2016 | M | 1,813 | $44.13 | A | 64,244 | D | |
| Ordinary Shares | holding | — | — | — | 2,480 | I | By Ira | |
| Ordinary Shares | holding | — | — | — | 4,800 | I | By Spouse Trust | |
| Ordinary Shares | holding | — | — | — | 25 | I | Cust/son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $46.91 | Jun 24, 2016 | M | 1,493 | D | — | Sep 1, 2016 | Ordinary Shares | 1,493 | 0 | D |
| Stock Option (Right to Buy)F2 | $52.84 | Jun 24, 2016 | M | 1,010 | D | — | Sep 1, 2017 | Ordinary Shares | 1,010 | 0 | D |
| Stock Option (Right to Buy)F3 | $50.34 | Jun 24, 2016 | M | 1,590 | D | — | Apr 28, 2018 | Ordinary Shares | 1,590 | 0 | D |
| Stock Option (Right to Buy)F4 | $29.96 | Jun 24, 2016 | M | 2,671 | D | — | Apr 27, 2019 | Ordinary Shares | 2,671 | 0 | D |
| Stock Option (Right to Buy)F5 | $44.13 | Jun 24, 2016 | M | 1,813 | D | — | May 3, 2020 | Ordinary Shares | 1,813 | 0 | D |
Explanation of responses
- F1This option to purchase 1,493 New Medtronic ordinary shares for $46.91 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,493 Medtronic common stock shares for $46.91 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F2This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F3This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F5This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.